Published physiology
Peer-reviewed work and established scientific literature used to ground autonomic regulation, HRV, sleep, metabolism, rPPG and related mechanisms.
NeuraGrip™ Science
DON'T TAKE OUR WORD FOR IT.
Follow the evidence behind the framework. See what is established, what MI.BO. has observed, what is still being investigated, and every source cited in You Are NeuraGripped.
Established physiologyObserved patternsInvestigating hypothesesSource-level evidenceLimits made visibleEstablished physiologyObserved patternsInvestigating hypothesesSource-level evidenceLimits made visible
Three evidence doors
Clearer claims. Better trust.
NeuraGrip separates published physiology from MI.BO. observations and from hypotheses that still require prospective validation.
MI.BO. observations
Patterns seen in MI.BO. datasets or internal wellness observations. These are presented as observations, not universal causal findings.
NeuraGrip hypotheses
New constructs, proposed relationships and mechanistic questions that remain open to formal validation and prospective study.
Evidence domains
One framework. Multiple scientific layers.
The bibliography spans physiology, stress biology, sleep, metabolism, ageing, interoception, environment, posture, GLP-1 science and muscle preservation.
Autonomic regulation & HRV
Vagal function, neurovisceral integration, HRV standards and recovery dynamics.
Allostatic load & cortisol
Cumulative physiological demand, HPA-axis behaviour and the cortisol awakening response.
Sleep & circadian biology
Sleep-wake timing, endocrine function and light-related disruption.
Posture, sensory environment & movement
Biomechanics, restorative environments, screen exposure and exercise physiology.
GLP-1 & metabolic signalling
Therapeutic efficacy, vagal pathways, autonomic effects, plateau, discontinuation and body composition.
Remote PPG measurement
Foundational camera-based pulse sensing and the measurement context behind remote physiological observation.
From claim to source
We show where the evidence starts and where it stops.
A citation should not decorate a claim. It should let the reader inspect the source, its use and its limits.
01CLAIM
The statement being made in the book, report or platform.
02EVIDENCE CLASS
Established, Observed or Investigating.
03WHY WE CITE IT
The specific proposition the source is being used to support.
04LIMITATIONS
What the paper cannot establish and what should not be inferred.
05SOURCE
The archived paper or bibliographic record in the MI.BO. Evidence Vault.
Appendix A.4 · Master bibliography
The complete evidence list from the book.
The printed bibliography is preserved exactly by reference number. Reference 79b is retained as a supplemental record rather than silently renumbered.
82 evidence records
1
Foundational Autonomic Physiology · NG-BIB-001
OPEN EVIDENCE →
Thayer, J. F., & Lane, R. D. (2007). The role of vagal function in the risk for cardiovascular disease and mortality. Biological Psychology, 74(2), 224-242.
2
Foundational Autonomic Physiology · NG-BIB-002
OPEN EVIDENCE →
Thayer, J. F., & Lane, R. D. (2000). A model of neurovisceral integration in emotion regulation and dysregulation. Journal of Affective Disorders, 61(3), 201-216.
3
Foundational Autonomic Physiology · NG-BIB-003
OPEN EVIDENCE →
Thayer, J. F., Yamamoto, S. S., & Brosschot, J. F. (2010). The relationship of autonomic imbalance, heart rate variability, and cardiovascular disease risk factors. International Journal of Cardiology, 141(2), 122-131.
4
Foundational Autonomic Physiology · NG-BIB-004
OPEN EVIDENCE →
Berthoud, H. R., & Neuhuber, W. L. (2000). Functional and chemical anatomy of the afferent vagal system. Autonomic Neuroscience: Basic and Clinical, 85(1-3), 1-17.
5
Foundational Autonomic Physiology · NG-BIB-005
OPEN EVIDENCE →
Tsuji, H., et al. (1996). Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation, 94(11), 2850-2855.
6
Foundational Autonomic Physiology · NG-BIB-006
OPEN EVIDENCE →
Benichou, T., et al. (2018). Heart rate variability in type 2 diabetes mellitus: a systematic review and meta-analysis. PLOS ONE, 13(4), e0195166.
7
Foundational Autonomic Physiology · NG-BIB-007
OPEN EVIDENCE →
Nunan, D., Sandercock, G. R., & Brodie, D. A. (2010). A quantitative systematic review of normal values for short-term HRV in healthy adults. Pacing and Clinical Electrophysiology, 33(11), 1407-1417.
8
Foundational Autonomic Physiology · NG-BIB-008
OPEN EVIDENCE →
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996). Heart rate variability: standards of measurement, physiological interpretation, and clinical use. European Heart Journal, 17(3), 354-381.
9
Foundational Autonomic Physiology · NG-BIB-009
OPEN EVIDENCE →
Shaffer, F., & Ginsberg, J. P. (2017). An overview of heart rate variability metrics and norms. Frontiers in Public Health, 5, 258.
10
Foundational Autonomic Physiology · NG-BIB-010
OPEN EVIDENCE →
Lehrer, P. M., & Gevirtz, R. (2014). Heart rate variability biofeedback: how and why does it work? Frontiers in Psychology, 5, 756.
11
Foundational Autonomic Physiology · NG-BIB-011
OPEN EVIDENCE →
Verkruysse, W., Svaasand, L. O., & Nelson, J. S. (2008). Remote plethysmographic imaging using ambient light. Optics Express, 16(26), 21434-21445.
12
Foundational Autonomic Physiology · NG-BIB-012
OPEN EVIDENCE →
de Haan, G., & Jeanne, V. (2013). Robust pulse rate from chrominance-based rPPG. IEEE Transactions on Biomedical Engineering, 60(10), 2878-2886.
13
Allostatic Load and Cumulative Stress · NG-BIB-013
OPEN EVIDENCE →
McEwen, B. S., & Stellar, E. (1993). Stress and the individual: mechanisms leading to disease. Archives of Internal Medicine, 153(18), 2093-2101.
14
Allostatic Load and Cumulative Stress · NG-BIB-014
OPEN EVIDENCE →
McEwen, B. S. (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338(3), 171-179.
15
Allostatic Load and Cumulative Stress · NG-BIB-015
OPEN EVIDENCE →
McEwen, B. S. (2008). Central effects of stress hormones in health and disease. European Journal of Pharmacology, 583(2-3), 174-185.
16
Allostatic Load and Cumulative Stress · NG-BIB-016
OPEN EVIDENCE →
Juster, R. P., McEwen, B. S., & Lupien, S. J. (2010). Allostatic load biomarkers of chronic stress and impact on health and cognition. Neuroscience & Biobehavioral Reviews, 35(1), 2-16.
17
HPA Axis and Cortisol Dynamics · NG-BIB-017
OPEN EVIDENCE →
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews, 21(1), 55-89.
18
HPA Axis and Cortisol Dynamics · NG-BIB-018
OPEN EVIDENCE →
Adam, E. K., et al. (2017). Diurnal cortisol slopes and health outcomes: a systematic review and meta-analysis. Psychoneuroendocrinology, 83, 25-41.
19
HPA Axis and Cortisol Dynamics · NG-BIB-019
OPEN EVIDENCE →
Wüst, S., Wolf, J., Hellhammer, D. H., Federenko, I., Schommer, N., & Kirschbaum, C. (2000). The cortisol awakening response, normal values and confounds. Noise and Health, 2(7), 79-88.
20
HPA Axis and Cortisol Dynamics · NG-BIB-020
OPEN EVIDENCE →
Clow, A., Hucklebridge, F., Stalder, T., Evans, P., & Thorn, L. (2010). The cortisol awakening response: more than a measure of HPA axis function. Neuroscience & Biobehavioral Reviews, 35(1), 97-103.
21
HPA Axis and Cortisol Dynamics · NG-BIB-021
OPEN EVIDENCE →
Stalder, T., et al. (2016). Assessment of the cortisol awakening response: expert consensus guidelines. Psychoneuroendocrinology, 63, 414-432.
22
HPA Axis and Cortisol Dynamics · NG-BIB-022
OPEN EVIDENCE →
Wüst, S., Federenko, I., Hellhammer, D. H., & Kirschbaum, C. (2000). Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology, 25(7), 707-720.
23
Metabolism, Insulin Resistance & Glucose Regulation · NG-BIB-023
OPEN EVIDENCE →
Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. Journal of Clinical Investigation, 106(4), 473-481.
24
Metabolism, Insulin Resistance & Glucose Regulation · NG-BIB-024
OPEN EVIDENCE →
Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. Journal of Clinical Investigation, 106(2), 171-176.
25
Metabolism, Insulin Resistance & Glucose Regulation · NG-BIB-025
OPEN EVIDENCE →
DeFronzo, R. A. (2004). Pathogenesis of type 2 diabetes mellitus. Medical Clinics of North America, 88(4), 787-835.
26
Ageing, Telomere Biology & Epigenetic Regulation · NG-BIB-026
OPEN EVIDENCE →
Epel, E. S., et al. (2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences, 101(49), 17312-17315.
27
Ageing, Telomere Biology & Epigenetic Regulation · NG-BIB-027
OPEN EVIDENCE →
Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome Biology, 14(10), R115.
28
Ageing, Telomere Biology & Epigenetic Regulation · NG-BIB-028
OPEN EVIDENCE →
Zannas, A. S., et al. (2015). Lifetime stress accelerates epigenetic aging in an urban, African American cohort. Proceedings of the National Academy of Sciences, 112(42), E6003-E6012.
29
Ageing, Telomere Biology & Epigenetic Regulation · NG-BIB-029
OPEN EVIDENCE →
Oh, H. S.-H., et al. (2023). Organ aging signatures in the plasma proteome track health and disease. Nature, 624, 164-172.
30
Ageing, Telomere Biology & Epigenetic Regulation · NG-BIB-030
OPEN EVIDENCE →
Ahadi, S., et al. (2020). Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nature Medicine, 26(1), 83-90.
31
Somatic Regulation, Trauma & Exercise Physiology · NG-BIB-031
OPEN EVIDENCE →
Levine, P. A. (1997). Waking the Tiger: Healing Trauma. North Atlantic Books. [Clinical framework text; not a controlled research study.]
32
Somatic Regulation, Trauma & Exercise Physiology · NG-BIB-032
OPEN EVIDENCE →
Payne, P., Levine, P. A., & Crane-Godreau, M. A. (2015, corrected). Somatic experiencing: using interoception and proprioception as core elements of trauma therapy. Frontiers in Psychology, 6, 93.
33
Somatic Regulation, Trauma & Exercise Physiology · NG-BIB-033
OPEN EVIDENCE →
van der Kolk, B. A. (2014). The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. Viking. [Clinical synthesis text; not a controlled research study.]
34
Somatic Regulation, Trauma & Exercise Physiology · NG-BIB-034
OPEN EVIDENCE →
Dishman, R. K., et al. (2006). Neurobiology of exercise. Obesity (Silver Spring), 14(3), 345-356.
35
Somatic Regulation, Trauma & Exercise Physiology · NG-BIB-035
OPEN EVIDENCE →
Green, D. J., Maiorana, A., O'Driscoll, G., & Taylor, R. (2004). Effect of exercise training on endothelium-derived nitric oxide function in humans. The Journal of Physiology, 561(1), 1-25.
36
Somatic Regulation, Trauma & Exercise Physiology · NG-BIB-036
OPEN EVIDENCE →
Tanaka, H., Dinenno, F. A., Monahan, K. D., Clevenger, C. M., DeSouza, C. A., & Seals, D. R. (2000). Aging, habitual exercise, and dynamic arterial compliance. Circulation, 102(11), 1270-1275.
37
Polyvagal Theory, Social Connection & Loneliness Physiology · NG-BIB-037
OPEN EVIDENCE →
Porges, S. W. (2007). The polyvagal perspective. Biological Psychology, 74(2), 116-143.
38
Polyvagal Theory, Social Connection & Loneliness Physiology · NG-BIB-038
OPEN EVIDENCE →
Grossman, P. (2023). Fundamental challenges and likely refutations of the five basic premises of the polyvagal theory. Biological Psychology, 180, 108589. [Critical review; included for balanced representation of the literature.]
39
Polyvagal Theory, Social Connection & Loneliness Physiology · NG-BIB-039
OPEN EVIDENCE →
Hawkley, L. C., & Cacioppo, J. T. (2010). Loneliness matters: a theoretical and empirical review of consequences and mechanisms. Annals of Behavioral Medicine, 40(2), 218-227.
40
Polyvagal Theory, Social Connection & Loneliness Physiology · NG-BIB-040
OPEN EVIDENCE →
Teo, J. T., Johnstone, S. J., Römer, S. S., & Thomas, S. J. (2022). Psychophysiological mechanisms underlying the potential health benefits of human-dog interactions: A systematic literature review. International Journal of Psychophysiology, 180, 27-48.
41
Brain-Body Integration & Interoception · NG-BIB-041
OPEN EVIDENCE →
LeDoux, J. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155-184.
42
Brain-Body Integration & Interoception · NG-BIB-042
OPEN EVIDENCE →
LeDoux, J. E., & Pine, D. S. (2016). Using neuroscience to help understand fear and anxiety: a two-system framework. American Journal of Psychiatry, 173(11), 1083-1093.
43
Brain-Body Integration & Interoception · NG-BIB-043
OPEN EVIDENCE →
Critchley, H. D., & Harrison, N. A. (2013). Visceral influences on brain and behavior. Neuron, 77(4), 624-638.
44
Circadian Biology & Sleep Regulation · NG-BIB-044
OPEN EVIDENCE →
Czeisler, C. A., & Buxton, O. M. (2017). The human circadian timing system and sleep-wake regulation. In Kryger, Roth & Dement (Eds.), Principles and Practice of Sleep Medicine (6th ed.), Elsevier.
45
Circadian Biology & Sleep Regulation · NG-BIB-045
OPEN EVIDENCE →
Spiegel, K., Leproult, R., & Van Cauter, E. (1999). Impact of sleep debt on metabolic and endocrine function. The Lancet, 354(9188), 1435-1439.
46
Environment & Restorative Physiology · NG-BIB-046
OPEN EVIDENCE →
Ulrich, R. S., et al. (1991). Stress recovery during exposure to natural and urban environments. Journal of Environmental Psychology, 11(3), 201-230.
47
Environment & Restorative Physiology · NG-BIB-047
OPEN EVIDENCE →
Kaplan, S. (1995). The restorative benefits of nature: toward an integrative framework. Journal of Environmental Psychology, 15(3), 169-182.
48
Environment & Restorative Physiology · NG-BIB-048
OPEN EVIDENCE →
Taylor, R. P., et al. (2006). Reduction of physiological stress using fractal art and architecture. Leonardo, 39(3), 245-251. [Fractal visual complexity and stress reduction.]
49
Posture, Cervical Biomechanics, and HRV · NG-BIB-049
OPEN EVIDENCE →
Chen, H., Tse, M. M. Y., Chung, J. W. Y., Yau, S. Y., & Wong, T. K. S. (2023). Effects of posture on heart rate variability in non-frail and prefrail individuals: a cross-sectional study. BMC Geriatrics, 23, 870.
50
Posture, Cervical Biomechanics, and HRV · NG-BIB-050
OPEN EVIDENCE →
Hansraj, K. K. (2014). Assessment of stresses in the cervical spine caused by posture and position of the head [biomechanical model; Surgical Technology International, low-impact letter; load values are modelling estimates]. Surgical Technology International, 25, 277-279. PMID:25393825.
51
Visual System and Screen Exposure · NG-BIB-051
OPEN EVIDENCE →
Rosenfield, M. (2011). Computer vision syndrome: a review of ocular causes and potential treatments [ocular symptoms; not autonomic activation]. Ophthalmic and Physiological Optics, 31(5), 502-515.
52
Visual System and Screen Exposure · NG-BIB-052
OPEN EVIDENCE →
Sheppard, A. L., & Wolffsohn, J. S. (2018). Digital eye strain: prevalence, measurement and amelioration. BMJ Open Ophthalmology, 3(1), e000146. doi:10.1136/bmjophth-2018-000146.
53
Visual System and Screen Exposure · NG-BIB-053
OPEN EVIDENCE →
Chang, A. M., et al. (2015). Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proceedings of the National Academy of Sciences, 112(4), 1232-1237. [Evening light-emitting screen exposure, melatonin suppression, circadian delay, sleep disruption, and next-morning alertness.]
54
GLP-1 Vagal Pathways, Therapies & Pharmacological Metabolic Intervention · NG-BIB-054
OPEN EVIDENCE →
Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (STEP 1 Study Group) (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 384(11), 989-1002.
55
GLP-1 Vagal Pathways, Therapies & Pharmacological Metabolic Intervention · NG-BIB-055
OPEN EVIDENCE →
Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 387, 205-216.
56
GLP-1 Vagal Pathways, Therapies & Pharmacological Metabolic Intervention · NG-BIB-056
OPEN EVIDENCE →
Brierley, D. I., & de Lartigue, G. (2022). Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating. British Journal of Pharmacology, 179(4), 584-599.
57
GLP-1 Vagal Pathways, Therapies & Pharmacological Metabolic Intervention · NG-BIB-057
OPEN EVIDENCE →
Sun, F., Wu, S., Guo, S., et al. (2015). Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among subjects with type 2 diabetes: a systematic review and network meta-analysis. Diabetes Research and Clinical Practice, 110, 26-37.
58
GLP-1 Vagal Pathways, Therapies & Pharmacological Metabolic Intervention · NG-BIB-058
OPEN EVIDENCE →
Grosicki, G. J., Kim, J., Fielding, F., et al. (2025). Heart and health behavior responses to GLP-1 receptor agonists: a 12-week study using wearable technology and causal inference. American Journal of Physiology–Heart and Circulatory Physiology, 328(2), H235-H241.
59
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-059
OPEN EVIDENCE →
Hall, K. D. (2024). Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery. Obesity (Silver Spring), published April 2024, 32(6), 1163-1168.
60
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-060
OPEN EVIDENCE →
Hansen, C. S., Frandsen, C. S., Fleischer, J., et al. (2019). Liraglutide-induced weight loss may be affected by autonomic regulation in type 1 diabetes. Frontiers in Endocrinology, 10, 242. [Lira-1 RCT; n=99 (50 liraglutide/49 placebo), overweight type 1 diabetes; cited as a mechanistic signal for the autonomic–GLP-1 interaction, not population-level proof.]
61
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-061
OPEN EVIDENCE →
Berg, S., Stickle, H., Rose, S. J., & Nemec, E. C. (2025). Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis. Obesity Reviews, 26(8), e13929.
62
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-062
OPEN EVIDENCE →
Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (STEP 1 Study Group) (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564.
63
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-063
OPEN EVIDENCE →
Rubino, D., Abrahamsson, N., Davies, M., et al. (STEP 4 Investigators) (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425.
64
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-064
OPEN EVIDENCE →
Aronne, L. J., Sattar, N., Horn, D. B., et al. (SURMOUNT-4 Investigators) (2024). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38-48.
65
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-065
OPEN EVIDENCE →
Liu, Q. K. (2024). Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists. Frontiers in Endocrinology, 15, 1431292.
66
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-066
OPEN EVIDENCE →
Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (STEP 1 Study Group) (2021). Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. Journal of the Endocrine Society, 5(Suppl 1), A16-A17.
67
GLP-1 Plateau, Weight Regain, Muscle Function & Autonomic Receptivity · NG-BIB-067
OPEN EVIDENCE →
Alissou, M., Demangeat, T., Folope, V., et al. (2026). Impact of semaglutide on fat mass, lean mass and muscle function in patients with obesity: the SEMALEAN study. Diabetes, Obesity and Metabolism, 28(1), 112-121.
68
Post-Pandemic Autonomic Sequelae & Vagal Function · NG-BIB-068
OPEN EVIDENCE →
Acanfora, D., et al. (2022). Impaired vagal activity in long-COVID-19 subjects. Viruses, 14(5), 1035.
69
Post-Pandemic Autonomic Sequelae & Vagal Function · NG-BIB-069
OPEN EVIDENCE →
Marques, K. C., et al. (2022). Reduction of cardiac autonomic modulation and increased sympathetic activity in subjects with long COVID. Frontiers in Cardiovascular Medicine, 9, 862001.
70
Post-Pandemic Autonomic Sequelae & Vagal Function · NG-BIB-070
OPEN EVIDENCE →
Asarcikli, L. D., et al. (2022). Heart rate variability and cardiac autonomic functions in post-COVID period. Journal of Interventional Cardiac Electrophysiology, 63(3), 715-721.
71
Post-Pandemic Autonomic Sequelae & Vagal Function · NG-BIB-071
OPEN EVIDENCE →
Camici, M., Del Duca, G., Brita, A. C., & Antinori, A. (2024). Connecting dots of long COVID-19 pathogenesis: a vagus nerve–hypothalamic-pituitary-adrenal–mitochondrial axis dysfunction. Frontiers in Cellular and Infection Microbiology, 14, 1501949.
72
Post-Pandemic Autonomic Sequelae & Vagal Function · NG-BIB-072
OPEN EVIDENCE →
Woo, M. S., Shafiq, M., Fitzek, A., et al. (2023). Vagus nerve inflammation contributes to dysautonomia in COVID-19. Acta Neuropathologica, 146(3), 387-394.
73
Protein Intake, Muscle Protein Synthesis & GLP-1 Nutrient Delivery · NG-BIB-073
OPEN EVIDENCE →
Moore, D. R., Robinson, M. J., Fry, J. L., et al. (2009). Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. American Journal of Clinical Nutrition, 89(1), 161-168.
74
Protein Intake, Muscle Protein Synthesis & GLP-1 Nutrient Delivery · NG-BIB-074
OPEN EVIDENCE →
Herreman, L., Nommensen, P., Pennings, B., & Laus, M. C. (2020). Comprehensive overview of the quality of plant- and animal-sourced proteins based on the digestible indispensable amino acid score. Food Science & Nutrition, 8(10), 5379-5391.
75
Protein Intake, Muscle Protein Synthesis & GLP-1 Nutrient Delivery · NG-BIB-075
OPEN EVIDENCE →
Jalleh, R. J., Plummer, M. P., Marathe, C. S., Umapathysivam, M. M., Quast, D. R., Rayner, C. K., Jones, K. L., Wu, T., Horowitz, M., & Nauck, M. A. (2025). Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide. Journal of Clinical Endocrinology & Metabolism, 110(1), 1-15. Correction: 110(10), e3556.
76
Protein Intake, Muscle Protein Synthesis & GLP-1 Nutrient Delivery · NG-BIB-076
OPEN EVIDENCE →
Boirie, Y., Dangin, M., Gachon, P., Vasson, M. P., Maubois, J. L., & Beaufrère, B. (1997). Slow and fast dietary proteins differently modulate postprandial protein accretion. Proceedings of the National Academy of Sciences, 94(26), 14930-14935.
77
Protein Intake, Muscle Protein Synthesis & GLP-1 Nutrient Delivery · NG-BIB-077
OPEN EVIDENCE →
Churchward-Venne, T. A., Burd, N. A., Mitchell, C. J., et al. (2012). Supplementation of a suboptimal protein dose with leucine or essential amino acids: effects on myofibrillar protein synthesis at rest and following resistance exercise in men. The Journal of Physiology, 590(11), 2751-2765.
78
Protein Intake, Muscle Protein Synthesis & GLP-1 Nutrient Delivery · NG-BIB-078
OPEN EVIDENCE →
Hamilton, M. T., Hamilton, D. G., & Zderic, T. W. (2022). A potent physiological method to magnify and sustain soleus oxidative metabolism improves glucose and lipid regulation. iScience, 25(9), 104869.
79
Body Composition, Discontinuation & Metabolic Rebound · NG-BIB-079
OPEN EVIDENCE →
Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024). Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism, 26(Suppl. 4), 16-27.
79b
Body Composition, Discontinuation & Metabolic Rebound · NG-BIB-079B
OPEN EVIDENCE →
Sattar, N., Neeland, I. J., Dahlqvist Leinhard, O., et al. (2025). Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial. The Lancet Diabetes & Endocrinology, 13(6), 482-493.
80
Body Composition, Discontinuation & Metabolic Rebound · NG-BIB-080
OPEN EVIDENCE →
Budini, B., Luo, S., et al. (2026). Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression. eClinicalMedicine, 93, 103796.
81
Body Composition, Discontinuation & Metabolic Rebound · NG-BIB-081
OPEN EVIDENCE →
Tzang, C. C., Wu, P. H., Luo, C. A., et al. (2025). Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. eClinicalMedicine, 90, 103680.
No bibliography records match that search.
Each evidence record opens in the MI.BO. Science Library, where available source material, citation context and limitations can be reviewed together.
Explore the wider MI.BO. science library
ONE EVIDENCE LIBRARY. A WIDER VIEW OF HUMAN BIOLOGY.
NeuraGrip is one part of a broader MI.BO. evidence library spanning MIBOSelfie, METAHUMAN, REFLECT and related work in physiology, bio-intelligence and human performance.